RNU6-660P

associated omics data
RNA, U6 small nuclear 660, pseudogeneGenealiases: []

Q-omics provides the consensus-scored RNU6-660P profile across patient tissues and cancer cell-line models. RNU6-660P expression is associated with patient survival in 11 of 34 cancer types, with the highest sampling consensus in PAAD. Additionally, RNU6-660P RNA expression shows 5,989 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight PAAD, and STAD as cancer lineages where RNU6-660P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Survival associations

This table summarizes RNU6-660P survival associations across molecular data types. RNU6-660P RNA expression shows survival associations in the most cancer types (11). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
RNU6-660P data typeSurvival analysisLineage consensusLineage of highest sampling consensus
RNAKaplan–Meier11PAAD (72)view →
This table ranks reproducible RNU6-660P RNA expression–survival associations across cancer types. High RNU6-660P expression shows unfavorable associations in PAAD, ACC, SARC, SKCM, BRCA and TGCT. The PAAD Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify PAAD as the clearest survival context for RNU6-660P RNA expression.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
PAADOSTertileAll0.1890.618<.00172view →
ACCOSTertileAll0.1330.686.00454view →
SARCOSTertileAll0.1080.839<.00136view →
SKCMDFSTertileIII,IV0.0890.601<.00130view →
BRCAOSTertileII,III,IV0.1650.568.00924view →
TGCTDFSTertileII,III,IV0.0880.917.01018view →
Pink = unfavorable, green = favorable. all 11 lineages →

RNU6-660P-PAAD (OS)

Kaplan–Meier survival curve for RNU6-660P RNA expression in PAAD: high vs low expression groups.

Explore this curve interactively →

Cross-omics associations

This table shows molecular features associated with RNU6-660P in patient tissues and cancer cell lines. In patient samples, RNU6-660P shows the broadest associations at the RNA and protein expression levels, with STAD recurring as the lineage with the largest associated feature set.
Associated data typeStrength (# associated data)Lineage of highest associated data
RNA
Function (RNA)5,989STAD (5551)view →
RNA5,850TGCT (2894)view →